The nationally recognized Henry Ford Medical Group is proud to introduce Minds of Medicine in Action, an educational resource for physicians featuring the latest research and innovations in patient care.
Cancer Continuing Medical Education Courses
As part of a major academic institution, the Henry Ford Cancer Institute offers a wide array of Continuing Medical Education (CME) courses – from weekly seminars to annual symposiums – covering the latest advancements in cancer research, clinical innovation and treatment.
Below is a listing of cancer-focused symposiums and seminars currently open for registration. To view a complete listing of all Henry Ford CME courses or to register for a course, visit our CME portal .
2019 Symposiums & Seminars
6th Annual Translational Oncology Research Symposium: Transforming the Blueprint for Pancreatic Cancer Research
Friday, November 15, 2019
Henry Ford Hospital – E&R Building, Room 2055
2799 W. Grand Blvd., Detroit, Michigan
- 7:30 a.m. Registration & Breakfast
- 8 a.m. AI for Early Detection and Cure – Regina Barzilay, Ph.D., Massachusetts Institute of Technology
- 8:45 a.m. Imaging-Based Biomarkers of Pancreatic Ductal Adenocarcinoma: Physical Reflections of Biology – Eugene Koay, M.D., Ph.D., The University of Texas MD Anderson Cancer Center
- 9:30 a.m. Multimodal Mapping of the Immune Landscape in Human Pancreatic Cancer - Marina Pasca di Magliano, Ph.D., University of Michigan Rogel Cancer Center
- 10:15 a.m. BREAK
- 10:30 a.m. New Concepts in Innate Immune Regulation of Pancreatic Cancer – George Miller, M.D., New York University Langone Medical Center
- 11:15 a.m. Keynote: Pancreatic Cancer Causation and Control – David Tuveson, M.D., Ph.D., Cold Spring Harbor Laboratory Cancer Center
- 12 p.m. LUNCH
- 1 p.m. Cellular Plasticity in Pancreatic Tumorigenesis and Pancreatic Cancer – Howard Crawford, Ph.D., University of Michigan Rogel Cancer Center
- 1:45 p.m. Treatment of Pancreatic Adenocarcinoma Through Iron Activated Drugs – Eric Collisson, M.D., University of California San Francisco Medical Center
- 2:30 p.m. Targeting Cancer at the Nuclear Pore – Asfar Azmi, Ph.D., Barbara Ann Karmanos Cancer Institute
- 3 p.m. Emerging Molecular Targets in Pancreatic Cancer – Anirban Maitra, M.B.B.S., The University of Texas MD Anderson Cancer Center
- 3:30 p.m. Conclusion & Closing Remarks
$50 for Physicians/Nurses/Fellows/Residents/Healthcare Professionals; Complimentary for all Henry Ford Employees and Medical Students.